Ligne de temps
 
									
								Juliette Paireau
																												Ingénieur(e) de Recherche
																	01 oct. 2024
								publication
									Effect of nirsevimab on hospitalisations for respiratory syncytial virus bronchiolitis in France, 2023-24: a modelling study.
Lire plus21 nov. 2023
								publication
									Comparing the Performance of Three Models Incorporating Weather Data to Forecast Dengue Epidemics in Reunion Island, 2018-2019.
Lire plus08 nov. 2023
								publication
									Impact of vaccination against severe COVID-19 in the French population aged 50 years and above: a retrospective population-based study.
Lire plus14 août 2023
								publication
									Two-dose measles vaccine effectiveness remains high over time: A French observational study, 2017-2019.
Lire plus01 janv. 2023
								publication
									Modelling the end of a Zero-COVID strategy using nirmatrelvir/ritonavir, vaccination and NPIs in Wallis and Futuna.
Lire plus15 août 2022
								publication
									Analytical framework to evaluate and optimize the use of imperfect diagnostics to inform outbreak response: Application to the 2017 plague epidemic in Madagascar.
Lire plus03 mai 2022
								publication
									An ensemble model based on early predictors to forecast COVID-19 health care demand in France.
Lire plus01 févr. 2022
								publication
									Impact of SARS-CoV-2 Delta variant on incubation, transmission settings and vaccine effectiveness: Results from a nationwide case-control study in France.
Lire plus01 févr. 2022
								
							01 janv. 2022
								publication
									Impact of booster vaccination on the control of COVID-19 Delta wave in the context of waning immunity: application to France in the winter 2021/22.
Lire plus25 nov. 2021
								publication
									SARS-CoV-2 transmission across age groups in France and implications for control.
Lire plus01 août 2021
								publication
									Exposures associated with SARS-CoV-2 infection in France: A nationwide online case-control study.
Lire plus26 juil. 2021
								
							01 juil. 2021
								publication
									Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: a modelling study, France, May to September 2021.
Lire plus01 juin 2021
								publication
									Evolution of outcomes for patients hospitalised during the first 9 months of the SARS-CoV-2 pandemic in France: A retrospective national surveillance data analysis.
Lire plus08 avr. 2021
								publication
									Monitoring the proportion of the population infected by SARS-CoV-2 using age-stratified hospitalisation and serological data: a modelling study.
Lire plus12 mars 2021
								publication
									Evaluating the impact of curfews and other measures on SARS-CoV-2 transmission in French Guiana.
Lire plus01 févr. 2021
								
							10 oct. 2020
								
							28 févr. 2019
								project
									Assessing the threat posed by zoonotic viruses like MERS-CoV, Nipah, Yellow Fever or plague
Lire plus28 févr. 2019
								
							28 févr. 2019
								project
									Statistical and mathematical methods to characterize disease transmission from incomplete epidemiological data
Lire plus18 mars 2017
								
							11 mai 2015